Skip to main content
HTFLHeartflow, Inc.Buy Wait6.1·$46.86

Heartflow (HTFL) Q2 2026 earnings — TrendMatrix coverage

BEAT · SMALLER LOSS+47.9% vs estimateEPS -$0.07 vs -$0.13 estVerdict Sell → Buy (Wait)

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy

Event detail · Q2 2026

Key numbers

Adjusted EPS
-$0.07
Estimate
-$0.13
Surprise
+47.9%
Revenue (period 2026-06-30)
$64.1M
Score at report (before → after)
4.5 → 5.6/10

Revenue source: xbrl.

Report record · Q2 2026

How the report landed

Heartflow (HTFL) reported a narrower loss than forecast — adjusted EPS of -$0.07 against the -$0.13 estimate (a 47.9% beat on a still-unprofitable quarter). TrendMatrix's engine moved from Sell (4.5/10) to Buy (Wait) at 5.6/10 after the report.

Around the report

Coverage in the report window

  • HeartFlow Shares Soar Following Strong Q2 Results and Upgraded Guidance — benzinga, 2026-08-14
  • Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45 — benzinga, 2026-08-14
  • Morgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40 — benzinga, 2026-08-14
Current read · as of 2026-11-17

Where TrendMatrix's rating stands now

TrendMatrix currently rates HTFL Buy (Wait) at 6.1/10.

3 of the last 4 quarters beat the estimate; this quarter's +47.9% surprise compares with a +34.1% four-quarter average. Next scheduled report: 2027-03-17.

What supports the rating

  • Strong earnings beat streak (3/4)
  • Positive news sentiment (+0.58)

What argues against it

  • Concentration risk — Product: Heartflow FFRCT Analysis (98.0%)
  • Value-trap signals (3/5): Margin compression (op margin -30.0%), Material insider selling (17 sells, 0.38% of cap), Negative free cash flow
  • News modifier +2: HOLD_IF_HOLDING → STRONG_BUY_WAIT

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$46.86
Entry target
$44.55
Price target
$54.92
Stop
$41.43
Upside to target
+17.2%
Reward-to-risk
1.1:1

Model outputs from TrendMatrix’s engine as of 2026-11-17 — shown for context, not personalized investment advice.

Healthcare context

HTFL at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Health Information Services
Market cap
$4.26B
P/E (fwd)
-182.8
P/E (ttm)
72.3
52-week range
$20.13–$60.66
Off 52-week high
22.7%
RSI (14)
36
Volume vs avg
0.87×
Score today
6.1/10

EPS and the estimate come from Yahoo Finance’s earnings calendar, captured around the report date. That EPS is the adjusted figure analysts forecast, so it can differ from the GAAP diluted EPS in the company’s filing, and consensus estimates vary between data providers. Revenue comes from SEC XBRL company facts where available, yfinance-provisional otherwise. Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home › Stocks › HTFL › Earnings › Q2 2026 earnings